BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 2811738)

  • 1. [Ketanserin. Lowering blood pressure using serotonin antagonists].
    Uhl D
    Med Monatsschr Pharm; 1989 Oct; 12(10):298-301. PubMed ID: 2811738
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mechanism of action and use of antagonists of serotonin receptors S2, especially ketanserin, in the treatment of various diseases of the cardiovascular system].
    Wiecek A; Grzeszczak W
    Pol Tyg Lek; 1987 Mar; 42(10):304-8. PubMed ID: 3299308
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of ketanserin in the treatment of the essential arterial hypertension associated with ischemic heart disease.
    Podoleanu D; Cotoi S
    Rom J Intern Med; 1996; 34(1-2):49-54. PubMed ID: 8908630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of ketanserin on blood pressure and platelets during cardiopulmonary bypass.
    Lichtenthal PR; Wade LD; Rossi EC
    Anesth Analg; 1987 Nov; 66(11):1151-4. PubMed ID: 3662060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketanserin, hypertension, and chronic alcoholism: double-blind study in forty patients.
    de Lorenzo A; Ceccanti M; Assogna G; Romeo M; Cavaleri G; Attilia ML
    Int J Clin Pharmacol Res; 1988; 8(5):321-5. PubMed ID: 3068159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of intravenous ketanserin on arterial and intracranial pressures in patients with systemic hypertension following intracerebral haemorrhage.
    Kay R; Poon WS; Nicholls MG
    J Hum Hypertens; 1993 Aug; 7(4):369-71. PubMed ID: 8410928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of ketanserin and metoprolol in the treatment of essential hypertension.
    Sheps SG; Schirger A; Zachariah PK; Fisher LD; Spiekerman RE; Araas FJ; Collins JB; Agerter DC
    Arch Intern Med; 1987 Feb; 147(2):291-6. PubMed ID: 3545116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotoninergic mechanisms in hypertension. Focus on the effects of ketanserin.
    Vanhoutte P; Amery A; Birkenhäger W; Breckenridge A; Bühler F; Distler A; Dormandy J; Doyle A; Frohlich E; Hansson L
    Hypertension; 1988 Feb; 11(2):111-33. PubMed ID: 3277910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effectiveness of ketanserin in the treatment of light-to-moderate arterial hypertension].
    Poletti L; Fogari R; Bressan MA; Poggio M; Daglio M; Ripamonti L; Vlacos D; Azzaretti G
    Clin Ter; 1993 Sep; 143(3):213-7. PubMed ID: 8222552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prolonged treatment with ketanserin in essential hypertension and comparison with metoprolol].
    Finkielman S
    Medicina (B Aires); 1985; 45(4):447-9. PubMed ID: 3916016
    [No Abstract]   [Full Text] [Related]  

  • 11. [Serotonin and its physiological and pathophysiological roles. Ketanserin].
    Metelitsa TV
    Kardiologiia; 1989 Sep; 29(9):120-5. PubMed ID: 2687555
    [No Abstract]   [Full Text] [Related]  

  • 12. Ketanserin-induced baroreflex enhancement in spontaneously hypertensive rats depends on central 5-HT(2A) receptors.
    Shen FM; Wang J; Ni CR; Yu JG; Wang WZ; Su DF
    Clin Exp Pharmacol Physiol; 2007 Aug; 34(8):702-7. PubMed ID: 17600544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive treatment with ketanserin shows no evidence of vascular serotonin2-receptor and alpha 1-adrenoceptor blockade.
    Blauw GJ; Doorenbos CJ; Bruning TA; van Brummelen P; van Zwieten PA
    Drugs; 1990; 40 Suppl 4():42-4. PubMed ID: 1982654
    [No Abstract]   [Full Text] [Related]  

  • 14. [Calcium antagonists in therapy of arterial hypertension].
    Brandt D
    Wien Med Wochenschr; 1993; 143(19-20):510-3. PubMed ID: 8135033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serotonin antagonists for the treatment of hypertension].
    Bühler FR
    Schweiz Med Wochenschr; 1988 Sep; 118(36):1259-60. PubMed ID: 3175572
    [No Abstract]   [Full Text] [Related]  

  • 16. Blood pressure during a combination of ketanserin and hydrochlorothiazide.
    Ferrara LA; Fasano ML; Soro S; Farinaro E; Celentano E; Mancini M
    Int J Clin Pharmacol Res; 1987; 7(6):463-8. PubMed ID: 3440636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive mechanism of ketanserin in postoperative hypertension after cardiopulmonary bypass.
    Anger C; Carter JA; Prys-Roberts C
    Anesth Analg; 1988 Feb; 67(2):99-106. PubMed ID: 3277483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin and the blood vessel wall.
    Vanhoutte PM; Lüscher TF
    J Hypertens Suppl; 1986 Apr; 4(1):S29-35. PubMed ID: 2939211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive properties of ketanserin (R 41 468).
    Vanhoutte PM; Van Nueten JM; Symoens J; Janssen PA
    Fed Proc; 1983 Feb; 42(2):182-5. PubMed ID: 6295821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin antagonism in the treatment of systemic hypertension: the role of ketanserin.
    Frishman WH; Okin S; Huberfeld S
    Med Clin North Am; 1988 Mar; 72(2):501-22. PubMed ID: 3279288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.